DS Healthcare Group Inc (NASDAQ:DSKX) CEO Yasuhiro Fujiwara acquired 2,500,000 shares of the stock in a transaction that occurred on Monday, July 17th. The shares were acquired at an average cost of $0.10 per share, with a total value of $250,000.00. Following the transaction, the chief executive officer now owns 2,815,000 shares in the company, valued at $281,500. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Shares of DS Healthcare Group Inc (DSKX) remained flat at $0.10 during midday trading on Tuesday. 3,894 shares of the stock traded hands. DS Healthcare Group Inc has a one year low of $0.01 and a one year high of $0.55. The company’s 50 day moving average is $0.06 and its 200-day moving average is $0.38.

WARNING: This piece was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international trademark and copyright law. The legal version of this piece can be read at https://www.americanbankingnews.com/2017/07/18/ds-healthcare-group-inc-dskx-ceo-buys-250000-00-in-stock.html.

About DS Healthcare Group

DS Healthcare Group, Inc, doing business as DS Laboratories, is a personal care, product development and marketing company. The Company develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs.

Receive News & Ratings for DS Healthcare Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DS Healthcare Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.